Hot Flashes and Fatigue on Hormone Therapy: Practical Ways the Care Team Helps

The waiting room is cool, almost chilly, yet the woman in the blue cardigan is fanning herself with a folded appointment sheet. Her neck is flushed. She started her breast cancer tablets six weeks ago, she tells the nurse, and the flashes arrive like clockwork at 3 a.m. and again in the checkout line. Two chairs over, a man on treatment for prostate cancer nods. He knows the drill: the heat, the sweat, then a tiredness that no nap seems to touch.

Both of them are dealing with hormone therapy side effects, hot flashes chief among them, and both have quietly wondered whether the treatment is worth it. That question deserves a straight answer, not reassurance on autopilot. The heat and the exhaustion are real, they have a clear biological cause, and they are not a sign the treatment is failing or the body is breaking.

What follows is what the evidence actually shows about why these symptoms happen, how long they tend to last, and the practical, tested ways a care team can help you keep going.

Why do hormone therapy side effects include hot flashes?

A hot flash is a sudden wave of heat, usually in the face, neck and chest, often followed by sweating and sometimes a chill. It is driven by the hypothalamus, the small region at the base of the brain that acts as the body’s thermostat.

Under normal conditions, the hypothalamus tolerates a fairly wide range of core temperature before it triggers cooling. Estrogen in women and testosterone in men help keep that tolerance zone wide. Cancer hormone therapy narrows it. The National Cancer Institute explains that when sex hormone levels fall abruptly, the thermostat begins reacting to tiny, ordinary shifts in core temperature as though the body were overheating. The result is a full cooling response: blood vessels near the skin dilate, the heart rate rises, sweat glands switch on. You feel the flush and the drip, then the rapid heat loss leaves you shivering.

Different treatments get there by different routes. Tamoxifen, a selective estrogen receptor modulator, blocks estrogen from reaching breast tissue and also influences the brain’s estrogen signaling. Aromatase inhibitors stop the body converting other hormones into estrogen after menopause, so circulating estrogen drops very low. In prostate cancer, androgen deprivation therapy uses injections or tablets to shut down testosterone production or block its receptor. In every case the brain registers a hormone withdrawal.

The National Cancer Institute reports that roughly two-thirds of women with a history of breast cancer experience hot flashes, and around three-quarters of men on androgen deprivation therapy do as well. The mechanism is the same physiology that drives menopausal flashes, compressed into weeks rather than years.

Cancer hormone therapy is not HRT, and the difference changes everything

Search for this topic and most results describe hormone replacement therapy for menopause, where estrogen is added to relieve symptoms. Cancer hormone therapy, also called endocrine therapy, does the opposite. It removes or blocks the hormones that some breast and prostate cancers use to grow.

That reversal is why standard menopause advice can point the wrong way. A woman taking an aromatase inhibitor is not “low on estrogen” by accident; the treatment is designed to keep estrogen low because her tumor tested positive for estrogen receptors. Adding estrogen back would work against the goal of therapy, which is why oncology teams generally avoid it, as the National Cancer Institute breast cancer hormone therapy fact sheet describes.

Duration also differs. Menopause hormone replacement is often reviewed yearly and stopped when symptoms settle. Endocrine therapy for breast cancer is typically prescribed for five years, and for some people up to ten, according to the National Cancer Institute. Androgen deprivation for prostate cancer may run for months alongside radiation or continue long term, depending on the stage and the treatment plan.

Knowing which kind of hormone therapy you are on tells you which evidence applies. The general principles of cooling, exercise and sleep hygiene carry over from menopause research. The medicine options do not carry over cleanly, because anything containing estrogen or testosterone is usually off the table, and some drugs interact with tamoxifen. Every option discussed in this article should be filtered through that lens by the team that prescribes your treatment.

Who usually gets these symptoms, and who is usually asked to wait before treating them

Hot flashes and fatigue can affect anyone on endocrine therapy, but a few patterns are consistent across guidelines. Women who were premenopausal at diagnosis and are pushed into a sudden menopause by ovarian suppression or chemotherapy often report the most intense flashes, because the hormonal drop is steep rather than gradual. Women already past menopause may have had flashes settle years earlier, only to see them return when an aromatase inhibitor is started. Men beginning androgen deprivation typically notice flashes within weeks of the first injection, alongside a slow shift toward less muscle and more body fat that feeds fatigue.

Who is asked to wait? Generally, people in the first two to three months of treatment. Care teams often hold off on adding a medicine for hot flashes early on, for two reasons. First, the National Cancer Institute and other sources note that flashes frequently peak in the early months and then ease, so a drug started at week two may be treating a problem that is already fading. Second, starting two new medicines at once makes it impossible to know which one is causing a new headache or a change in mood.

People with certain other conditions are also steered carefully. Someone with a history of low blood pressure or fainting may not be offered a blood pressure medicine that is sometimes used for flashes. Someone on tamoxifen will have any antidepressant chosen with the interaction in mind. None of this is a refusal to help; it is sequencing. The team is separating what needs treating now from what is likely to improve on its own.

How long do hot flashes last after hormone therapy starts?

Two different clocks matter here, and people often confuse them.

The first is the length of a single flash. Mayo Clinic describes the typical episode lasting one to five minutes, though some people report longer. Frequency varies enormously, from one or two a day to more than a dozen, with nighttime episodes often the most disruptive.

The second clock is how long the pattern persists. The honest answer is that it varies by treatment and by person, and evidence gives ranges rather than promises. The National Cancer Institute notes that hot flashes related to tamoxifen often begin within weeks and, for many people, decline in intensity over the first several months as the body adapts to the new hormonal setting. With aromatase inhibitors, symptoms may be steadier for as long as the medicine continues, because estrogen stays consistently low rather than fluctuating. In men on androgen deprivation, flashes tend to persist while testosterone remains suppressed and often ease if therapy is paused or completed.

The word “adapt” matters. The hypothalamus does gradually reset its temperature tolerance in many people, which is why menopause flashes eventually stop even though estrogen never returns. Endocrine therapy seems to allow a similar, if incomplete, recalibration for some. Others continue to have flashes for the full course of treatment.

Fatigue follows a looser timeline. The National Cancer Institute describes cancer-related fatigue as commonly building over weeks and improving slowly after treatment changes, rather than switching off. Your care team cannot give you a date, but they can tell you whether your pattern is tracking the usual curve or veering off it.

What the first weeks and months usually look like

Expect a sequence rather than a single event. In the first one to two weeks, most people notice nothing dramatic. Hormone levels are shifting but the brain has not yet responded. Some men on certain prostate cancer injections briefly feel worse before they feel different, because testosterone can spike before it falls; the National Cancer Institute prostate cancer fact sheet describes this “flare” effect and the medicines sometimes used to cover it.

Weeks two to eight are when flashes usually announce themselves. Night sweats often arrive first, then daytime episodes tied to triggers like hot drinks, spicy food, alcohol, warm rooms or stress. Fatigue creeps in during the same window, frequently disguised as poor sleep from the night sweats.

Months two to six are the adaptation phase. This is when the care team watches closely. Many people find the flashes become less severe or less frequent, even if they do not vanish. Others reach a steady state that is tolerable with simple measures. A minority find the symptoms interfering with work, relationships or sleep to the point that a medicine is worth the trade-offs.

Beyond six months, symptoms are usually stable. Any new change, a sudden increase in flashes or an unexpected wave of exhaustion, deserves a call rather than a shrug, because it may signal something other than the hormone therapy.

Keeping a simple log through this period, noting flashes per day and a one-to-ten fatigue score, gives the team real data at each review. Patterns that feel random at 3 a.m. often look obvious on paper.

Hormone therapy side effects: hot flashes and fatigue at a glance

The two symptoms travel together but respond to different approaches. The table below summarizes what mainstream guidance says about each, so you can see where the levers are.

Feature	Hot flashes	Fatigue
What it feels like	Sudden heat in face, neck and chest; sweating; sometimes a chill afterward	Persistent tiredness not relieved by rest; heavy limbs; slowed thinking
Main mechanism	Narrowed temperature tolerance in the hypothalamus after hormone withdrawal	Multiple: disrupted sleep, hormonal shifts in muscle and metabolism, mood, anemia or thyroid changes in some cases
Typical onset	Weeks after starting treatment (NCI)	Builds gradually over weeks to months (NCI)
Common triggers	Warm rooms, hot drinks, alcohol, spicy food, stress	Poor sleep, inactivity, pain, low mood, dehydration
Best-evidenced non-drug approach	Layered clothing, cooling, trigger avoidance, cognitive behavioral therapy	Regular moderate exercise, sleep routine, activity pacing
Medicine options the team may consider	Certain antidepressants, gabapentin, oxybutynin, clonidine; choice depends on interactions	Treat underlying causes first; no single fatigue medicine is standard
When to flag urgently	Flashes with fever, chest pain or fainting	Exhaustion with breathlessness, palpitations, or inability to do daily tasks

One takeaway from the table matters more than the rest: fatigue is rarely one thing. The National Cancer Institute stresses that before anyone attributes tiredness to the hormone therapy alone, the team should check for reversible contributors such as anemia, thyroid changes, depression, pain or medicine interactions. Fixing one of those can lift the fog more than any flash remedy.

How to get rid of hormonal hot flashes: what lifestyle changes actually do

Nobody can promise to make flashes disappear, and the evidence for lifestyle measures is about reducing frequency and impact, not elimination. Within that honest boundary, several approaches are well supported by Mayo Clinic and NHS guidance.

Dress in layers you can peel off in seconds. Natural fibers and moisture-wicking fabrics move sweat away from skin faster than heavy cotton. Keep the bedroom cooler than feels natural, use lighter bedding, and consider a fan aimed at the bed; many people find a cool pack under the pillow to flip over helps them fall back asleep after a night sweat.

Identify your personal triggers and test them. Hot drinks, alcohol, caffeine and spicy food are the usual suspects, but they vary. Two weeks of noting what preceded each flash tells you which ones are yours.

Sip cool water at the first hint of heat. The physiology here is simple: lowering core temperature slightly can shorten the cooling cascade the brain has launched.

Paced breathing, slow breaths at roughly six per minute for a few minutes when a flash starts, has modest support in older studies; Mayo Clinic notes the evidence is mixed but the technique is harmless and some people find it useful.

Weight matters for some. Higher body fat is associated with more frequent flashes in menopause research, and for people whose treatment is driving weight gain, a plan built with the team, not a crash diet, can help on several fronts at once.

Smoking is consistently linked to more severe flashes, and quitting improves cancer outcomes generally. Support to stop is one of the highest-yield conversations you can have.

Non-hormonal medicines the care team may discuss

When flashes are frequent enough to wreck sleep or daily function, the prescribing clinician may raise medicine options. These are described here by class and mechanism only; whether any of them suits you, and at what point, is the team’s call.

Certain antidepressants, specifically some selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors such as venlafaxine, are among the best-studied non-hormonal treatments. They appear to work by influencing the brain chemicals that help set the temperature tolerance zone. Mayo Clinic and the National Cancer Institute both describe them as reducing flash frequency for many people, with effects usually noticed within a few weeks. One important detail: paroxetine and some related drugs interfere with the liver enzyme that activates tamoxifen, so they are generally avoided in people taking it. This is precisely why self-selecting is risky.

Gabapentin, originally a seizure medicine, also reduces flashes for some, and because it can cause drowsiness it is sometimes considered when night sweats are the main problem. Oxybutynin, a bladder medicine, has shown benefit in trials involving cancer survivors, with dry mouth the most common trade-off. Clonidine, a blood pressure drug, has a longer history and more modest effect.

A newer class, neurokinin 3 receptor antagonists, targets the brain circuit that drives flashes directly. The trials that led to approval enrolled women in natural menopause, not people on cancer endocrine therapy, so oncology teams treat its use in this setting as a case-by-case judgment, as Mayo Clinic notes.

Progestin hormones are occasionally used, particularly in men on androgen deprivation, but their role in breast cancer is debated. Every option carries side effects, and the right question for your team is which trade-off fits your life.

Why adding estrogen or testosterone back is usually off the table

People sometimes ask, reasonably, why they cannot simply take a small amount of the hormone they are missing. If the treatment removed it, why not put a little back to soften the landing?

The answer lies in the reason the treatment was prescribed. Hormone receptor-positive breast cancers carry proteins that bind estrogen and use it as a growth signal. Most prostate cancers rely on androgens the same way. The National Cancer Institute explains that endocrine therapy works by starving those cells of their signal or blocking the receptor. Reintroducing the hormone, even at low levels, risks handing the cancer the fuel the treatment was designed to withhold.

That is why systemic menopause hormone therapy is generally not recommended for women with a history of hormone-sensitive breast cancer, and why testosterone supplementation is not used during active androgen deprivation. It is not a matter of caution for its own sake; it follows directly from the mechanism.

There are nuances your team may raise. Vaginal dryness, a separate and common side effect, is sometimes managed with non-hormonal moisturizers first, and very low-dose local vaginal estrogen is debated in specific situations, with the oncologist weighing risk. “Bioidentical” hormones marketed as natural alternatives are still estrogen or testosterone at the receptor and carry the same theoretical concern; the label does not change the biology.

Understanding this logic helps in another way. When a friend or an online forum suggests a hormone-based remedy, you can recognize why your oncology team is likely to say no, and ask instead about the non-hormonal routes that remain open.

Fatigue on hormone therapy: why movement is the best-studied fix

It sounds backward. You are exhausted, and the advice is to exercise. Yet across cancer-related fatigue research, regular physical activity is the intervention with the most consistent evidence, and the National Cancer Institute lists it first among non-drug approaches.

The mechanisms are several. Endocrine therapy shifts body composition toward less muscle and more fat, which lowers baseline energy and makes ordinary tasks harder. Resistance exercise directly counters that loss. Aerobic activity improves sleep quality, which is often the hidden driver of daytime tiredness. Movement also acts on mood, and low mood and fatigue amplify each other.

The prescription that works is moderate and regular, not heroic. Guidance from major cancer bodies generally points toward brisk walking or similar activity on most days, building gradually, plus two sessions a week of strength work using bands, body weight or light weights. Someone who has never exercised can start with ten minutes and add from there. Someone who used to run may need to accept a slower pace for a while without reading it as defeat.

Pacing matters as much as doing. Fatigue on hormone therapy often follows a boom-and-bust pattern: a good day leads to overdoing it, followed by two flat days. Spreading activity evenly, and stopping before exhaustion rather than after, tends to raise the average rather than the peaks.

Before any program, the team should rule out contributors that exercise cannot fix. The National Cancer Institute specifically flags anemia, thyroid problems, depression, pain and medicine side effects. Bone health also deserves a check, because both aromatase inhibitors and androgen deprivation can thin bone, and the exercise plan may need to be tailored around that.

Night sweats, sleep and the fatigue loop

Ask people on endocrine therapy which symptom they would give up first, and many pick the night sweats over the daytime flashes. The reason is arithmetic. A single episode that wakes you at 2 a.m., followed by fifteen minutes of cooling off and changing a damp shirt, may cost only a fraction of the night. Three of them, five nights a week, quietly dismantle your sleep architecture and show up the next afternoon as fatigue that has nothing to do with muscle or metabolism.

Breaking the loop starts with the bedroom. Mayo Clinic’s practical suggestions include a cooler room, breathable bedding, a fan and layered nightwear so you can shed a layer without fully waking. Some people keep a spare top and towel by the bed to avoid turning on lights and rousing the brain further.

Behavioral sleep techniques also apply. Fixed wake times, limiting long daytime naps to short ones early in the day, and reducing screen light before bed help consolidate the sleep you do get. Alcohol is worth a specific mention: it can trigger flashes and fragments sleep in the second half of the night, a double penalty.

If night sweats remain the dominant problem after these measures, the care team has a specific reason to consider one of the medicine options that carries drowsiness as a side effect, taken in the evening. That is a clinical decision, but it illustrates how describing the pattern precisely, rather than saying “I am tired,” helps the team choose well.

One caution: night sweats with fever, weight loss or drenching that soaks bedding every night can have other causes and should be reported rather than assumed to be treatment-related.

Supplements, acupuncture and CBT: what holds up and what does not

This is the section where honesty matters most, because the wellness market is loud and the evidence is quiet.

Cognitive behavioral therapy, a structured talking therapy that changes how you respond to symptoms, has the strongest support among non-drug approaches. The NHS lists it as an option for menopausal hot flushes, and trials in breast cancer survivors suggest it reduces how much flashes interfere with daily life and improves sleep, even when flash frequency changes less. It does not require you to believe the flashes are imaginary; it teaches practical responses to a real physical event.

Acupuncture has mixed results. Some trials in cancer patients show reductions in flash frequency compared with no treatment, while comparisons against sham acupuncture are less convincing, as the National Cancer Institute summarizes. It appears safe when performed by a trained practitioner, and some people find it helpful, but the evidence does not support calling it effective in the way a medicine is.

Herbal and dietary supplements are where caution is essential. Black cohosh, evening primrose oil, red clover and soy isoflavones have been studied; the NIH Office of Dietary Supplements and the National Cancer Institute report that evidence for meaningful benefit is weak or inconsistent. Soy and red clover contain plant compounds that act weakly on estrogen receptors, which is why oncology teams often ask people with hormone-sensitive cancer to avoid concentrated supplements even if ordinary soy foods are generally considered fine. Some herbal products also affect the liver enzymes that process tamoxifen and other cancer medicines.

The rule that follows: tell the team about every supplement, including ones you consider harmless, before you start it, not after.

What people often get wrong

Myth: hot flashes mean the treatment is too strong or I am having a bad reaction. Reality: flashes are an expected effect of hormone withdrawal, not a sign of toxicity. The National Cancer Institute lists them among the most common, anticipated side effects.

Myth: hot flashes mean I have too much estrogen. Reality: in cancer hormone therapy the opposite is true. Flashes are triggered by falling or blocked hormone signaling. The confusion comes from menopause forums, where estrogen dominance is a popular but poorly defined idea.

Myth: if the flashes stop, the medicine has stopped working. Reality: the brain’s thermostat often recalibrates over months while hormone levels stay suppressed. Symptom relief and treatment effect are separate things, and only the team can assess the latter.

Myth: I can just skip doses on bad days. Reality: endocrine therapy works through steady suppression. Interruptions should never be self-managed; if side effects feel unbearable, that is a conversation to have urgently with the prescriber, who may have options including a different drug in the same class.

Myth: fatigue just means I need more rest. Reality: excessive rest can worsen cancer-related fatigue by accelerating muscle loss. The evidence favors regular, paced activity.

Myth: natural hormones are safe because they are natural. Reality: a plant-derived hormone binds the same receptor as a synthetic one. The origin does not change what it does to a hormone-sensitive cancer cell.

Myth: nobody else struggles this much, so I should just cope. Reality: the majority of people on these treatments report flashes, and many report fatigue. Reporting them is how the team helps.

Questions to ask your care team

Consultations are short and symptoms are easy to minimize once you are sitting in the chair. Bringing written questions changes the conversation. These are the ones that tend to yield useful answers.

• Which type of hormone therapy am I on, and what does that mean for which hot flash treatments are safe for me?
• Based on my treatment, what pattern of flashes and fatigue do you usually see over the first six months, and how will we know if mine is off track?
• Are there reversible causes of my fatigue you would like to check, such as blood counts, thyroid or vitamin levels?
• Is there an exercise or rehabilitation referral available, and should the plan account for bone density?
• Which non-hormonal medicines would you consider if my flashes do not settle, and which ones should I avoid because of interactions with my cancer treatment?
• Is cognitive behavioral therapy for hot flashes or sleep available through this service or by referral?
• If side effects become intolerable, what are the alternatives within my treatment plan, and who do I contact between appointments?
• Which supplements, if any, do you specifically want me to avoid?
• How should I keep a symptom record that is actually useful to you?

Notice what is not on the list: asking whether the treatment is worth continuing based on side effects alone. That is a legitimate concern, but it is a discussion about your overall cancer plan, and it belongs in a dedicated conversation with the oncologist rather than a hurried aside at the end of a review. Raise it, name it clearly, and ask for the time it deserves.

When to call your doctor

Most hot flashes and most tiredness on endocrine therapy are uncomfortable rather than dangerous, and the ordinary route is to describe them at your next scheduled review. Some situations should not wait.

Contact your care team the same day if you have a fever alongside sweats, especially if you are also having other cancer treatment; if flashes come with chest pain, pressure, a racing or irregular heartbeat, or fainting; if you develop sudden breathlessness, or pain and swelling in one calf, since hormone therapies including tamoxifen carry a small increased clot risk, as the National Cancer Institute notes; if fatigue becomes so severe that you cannot get out of bed or manage basic self-care; or if you notice unexplained weight loss, persistent nausea, yellowing of the skin or eyes, or new confusion.

Seek emergency care immediately for signs of stroke such as sudden weakness on one side, facial drooping or trouble speaking, or for chest pain that does not settle within minutes.

Call promptly, though not as an emergency, if night sweats are drenching every night and getting worse rather than better; if you feel persistently low, hopeless or anxious, because mood changes are common and treatable and they magnify fatigue; if you are considering stopping or skipping your hormone therapy because of side effects; or if a new symptom appears that does not fit the pattern you have been living with.

The threshold for calling is lower than most people set it. A five-minute conversation with a nurse specialist can distinguish an expected side effect from something that needs a look, and the team would rather hear from you early than late.

Frequently asked questions

Why am I getting hot flashes on hormone therapy?

Because the treatment lowers or blocks estrogen or testosterone, and the hypothalamus, the brain’s thermostat, relies on those hormones to tolerate small temperature changes. Without them it overreacts, triggering sweating and skin flushing to cool a body that was not actually overheated. This is an expected effect of hormone withdrawal described by the National Cancer Institute, not a sign the treatment is harming you or working incorrectly.

How long do hot flushes last after hormone therapy?

Each episode usually lasts one to five minutes according to Mayo Clinic. The broader pattern varies by treatment: tamoxifen-related flushes often ease over the first several months, aromatase inhibitors tend to produce steadier symptoms while treatment continues, and flushes on androgen deprivation persist while testosterone is suppressed. Your care team can compare your trajectory with the typical curve, but no one can promise a specific end date.

How to get rid of hormonal hot flashes completely?

Evidence supports reducing frequency and impact rather than eliminating flashes. Layered clothing, a cooler bedroom, avoiding personal triggers such as alcohol and hot drinks, quitting smoking and cognitive behavioral therapy all have support from Mayo Clinic and NHS guidance. If flashes still disrupt sleep or work, the prescribing clinician may consider non-hormonal medicines. Which one, and whether, depends on your cancer treatment and interactions.

Do hot flashes mean too much estrogen?

No. In cancer hormone therapy, flashes result from too little hormone signaling, not too much. Tamoxifen blocks estrogen receptors, aromatase inhibitors drive estrogen very low, and androgen deprivation removes testosterone. The idea of estrogen dominance causing flashes comes from menopause discussions and does not apply here. Adding hormones back is generally avoided because hormone-sensitive cancers can use them to grow.

Is fatigue on hormone therapy permanent?

Usually not, though it can last as long as treatment continues for some people. The National Cancer Institute describes cancer-related fatigue as building gradually and improving slowly once contributing factors are addressed. Regular paced exercise, better sleep and correcting problems such as anemia or thyroid changes can all reduce it during treatment. Many people notice improvement in the months after endocrine therapy ends.

Are hot flashes on tamoxifen different from those on aromatase inhibitors?

The sensation is the same, but the pattern can differ. Tamoxifen blocks estrogen receptors while allowing estrogen to circulate, and flashes often begin within weeks and settle somewhat over months for many people. Aromatase inhibitors keep estrogen consistently very low after menopause, which can produce steadier flashes and more joint stiffness. Your oncologist weighs these profiles when choosing or switching within the treatment plan.

Can men on androgen deprivation therapy get hot flashes too?

Yes, and very commonly. The National Cancer Institute reports that around three-quarters of men on androgen deprivation therapy experience hot flashes, because falling testosterone affects the brain’s thermostat in the same way falling estrogen does. Men often also notice fatigue, reduced muscle and increased body fat. The same cooling strategies, exercise and, when needed, non-hormonal medicines apply, chosen by the treating team.

Does exercise really help with fatigue on hormone therapy?

It has the most consistent evidence of any non-drug approach, according to the National Cancer Institute. Moderate aerobic activity most days plus two weekly strength sessions counters the muscle loss endocrine therapy causes, improves sleep and lifts mood. The key is starting small and pacing evenly rather than pushing on good days and collapsing afterward. A rehabilitation referral can tailor the plan around bone health and other conditions.

Are natural or bioidentical hormones safe to take for hot flashes during cancer treatment?

They are generally avoided. Plant-derived or compounded hormones bind the same receptors as any other estrogen or testosterone, so they can provide the growth signal that endocrine therapy is designed to remove. The National Cancer Institute explains that this is why systemic hormone replacement is not recommended for people with hormone-sensitive breast or prostate cancer. Ask the oncology team about non-hormonal alternatives instead.

Should I stop hormone therapy if the side effects are severe?

Not on your own. Endocrine therapy works through steady suppression, and interruptions or missed doses can undermine it. If flashes or fatigue feel unbearable, contact the prescribing team promptly; options may include treating the symptom, adjusting the plan or switching to a different medicine in the same class. That decision requires weighing your cancer risk against your quality of life, and only your treating team can make it with you.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.